This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Astellas Pharma Gmbh. Active years: 2012-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2014
Title: Unveiling the Innovator: Takaho Nomura
Introduction:
Takaho Nomura, a man of remarkable ingenuity, hails from the bustling city of Tokyo, Japan. With a profound passion for innovation, Nomura has left a lasting impact in the realm of patents, particularly in the field of pharmaceuticals.
Latest Patents:
Nomura's latest patents showcase his expertise in pharmaceutical research:
1. "Substituted imidazo[1,5-a]quinoxalin-4-ones as phosphodiesterase 9 inhibitors"
2. "Substituted imidazo[1,5-a]quinoxalin-4(5H)-ones as PDE9 inhibitors"
Career Highlights:
Currently thriving in the innovative environment of Astellas Pharma Gmbh, Nomura has proven himself as a valuable asset to the company. His dedication to advancing pharmaceutical research is reflected in the quality and impact of his patents.
Collaborations:
Nomura's collaborative spirit shines through his professional relationships with esteemed coworkers such as Hidenori Azami and Ryushi Seo. Together, they have contributed significantly to the advancement of pharmaceutical technologies.
Conclusion:
In conclusion, Takaho Nomura stands as a beacon of innovation in the field of pharmaceuticals. His relentless pursuit of cutting-edge solutions and collaborative efforts underscore his commitment to driving progress and shaping the future of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile